UA103104C2 - Аналоги инсулиноподобного фактора роста-1 (igf-1), содержащие аминокислотную замену в положении 59 - Google Patents
Аналоги инсулиноподобного фактора роста-1 (igf-1), содержащие аминокислотную замену в положении 59Info
- Publication number
- UA103104C2 UA103104C2 UAA201202007A UAA201202007A UA103104C2 UA 103104 C2 UA103104 C2 UA 103104C2 UA A201202007 A UAA201202007 A UA A201202007A UA A201202007 A UAA201202007 A UA A201202007A UA 103104 C2 UA103104 C2 UA 103104C2
- Authority
- UA
- Ukraine
- Prior art keywords
- analogues
- igf
- insulin
- amino acid
- growth factor
- Prior art date
Links
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 title abstract 3
- 102100037852 Insulin-like growth factor I Human genes 0.000 title abstract 3
- 238000006467 substitution reaction Methods 0.000 title abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 title abstract 2
- 101150088952 IGF1 gene Proteins 0.000 title 1
- 102000038455 IGF Type 1 Receptor Human genes 0.000 abstract 1
- 108010031794 IGF Type 1 Receptor Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 208000020221 Short stature Diseases 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
Изобретение касается аналогов инсулиноподобного фактора роста-1 (IGF-1), содержащих аминокислотную замену в положении 59, и другую(и) замену(и), фармацевтических композиций, которые содержат указанные аналоги, и применения указанных аналогов для лечения состояний или заболеваний, опосредованных связыванием рецептора IGF-1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27154909P | 2009-07-22 | 2009-07-22 | |
PCT/US2010/002062 WO2011011072A2 (en) | 2009-07-22 | 2010-07-22 | Analogues of insulin-like growth factor-1 (igf-1) having amino acid substitution at position 59 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA103104C2 true UA103104C2 (ru) | 2013-09-10 |
Family
ID=43499582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201202007A UA103104C2 (ru) | 2009-07-22 | 2010-07-22 | Аналоги инсулиноподобного фактора роста-1 (igf-1), содержащие аминокислотную замену в положении 59 |
Country Status (14)
Country | Link |
---|---|
US (1) | US8759299B2 (ru) |
EP (1) | EP2456788B1 (ru) |
JP (2) | JP5571186B2 (ru) |
KR (1) | KR101417872B1 (ru) |
CN (1) | CN102510757B (ru) |
AU (1) | AU2010275010B2 (ru) |
BR (1) | BR112012001363A2 (ru) |
CA (1) | CA2768621C (ru) |
ES (1) | ES2562260T3 (ru) |
HK (1) | HK1170748A1 (ru) |
MX (1) | MX2012000757A (ru) |
RU (1) | RU2511577C2 (ru) |
UA (1) | UA103104C2 (ru) |
WO (1) | WO2011011072A2 (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2511577C2 (ru) * | 2009-07-22 | 2014-04-10 | Ипсен Фарма С.А.С. | Аналоги инсулиноподобного фактора роста-1 (igf-1), содержащие аминокислотную замену в положении 59 |
WO2011146902A1 (en) | 2010-05-21 | 2011-11-24 | Merrimack Pharmaceuticals, Inc. | Bi-specific fusion proteins |
CN104011070A (zh) * | 2011-12-15 | 2014-08-27 | 爱德迪安(北京)生物技术有限公司 | 具有降血糖作用的化合物、组合物及其用途 |
CN108367048B (zh) | 2015-10-02 | 2022-08-12 | 银溪制药股份有限公司 | 用于组织修复的双特异性治疗性蛋白质 |
JP7248952B2 (ja) | 2019-03-22 | 2023-03-30 | 株式会社ジャノメ | 電動ミシン |
WO2023139250A1 (en) | 2022-01-24 | 2023-07-27 | Oak Hill Bio Limited | Lot release assays for igf‐1/igfbp complexes |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985000831A1 (en) | 1983-08-10 | 1985-02-28 | Amgen | Microbial expression of insulin-like growth factor |
JPS60501989A (ja) * | 1983-08-10 | 1985-11-21 | アムジエン | インシュリン様成長因子の微生物発現 |
US4888286A (en) * | 1984-02-06 | 1989-12-19 | Creative Biomolecules, Inc. | Production of gene and protein analogs through synthetic gene design using double stranded synthetic oligonucleotides |
GB8408473D0 (en) * | 1984-04-02 | 1984-05-10 | Fujisawa Pharmaceutical Co | 59 val-insulin-like growth factor i |
US4745179A (en) | 1984-04-02 | 1988-05-17 | Fujisawa Pharmaceutical Co., Ltd. | 59 Valine insulin-like growth factor I and process for production thereof |
US5242811A (en) * | 1985-03-26 | 1993-09-07 | Biogen, Inc. | Production of human somatomedin C |
US6310040B1 (en) | 1991-11-08 | 2001-10-30 | Cephalon, Inc. | Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
US5283241A (en) * | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
US5672659A (en) | 1993-01-06 | 1997-09-30 | Kinerton Limited | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
US5824642A (en) | 1994-04-07 | 1998-10-20 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
US5595760A (en) | 1994-09-02 | 1997-01-21 | Delab | Sustained release of peptides from pharmaceutical compositions |
US5665702A (en) | 1995-06-06 | 1997-09-09 | Biomeasure Incorporated | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
US5916883A (en) | 1996-11-01 | 1999-06-29 | Poly-Med, Inc. | Acylated cyclodextrin derivatives |
AU2329199A (en) | 1998-01-29 | 1999-08-16 | Poly-Med, Inc. | Absorbable microparticles |
WO2000004916A1 (en) | 1998-07-23 | 2000-02-03 | Societe De Conseils De Recherches Et D'applications Scientifiques Sas | Encapsulation of water soluble peptides |
AR020650A1 (es) | 1998-08-10 | 2002-05-22 | Poly Med Inc | Polimeros fosforilados y conjugados de los mismos |
CA2349346A1 (en) | 1998-11-02 | 2000-05-11 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R | Lactone bearing absorbable polymers |
JP2002535967A (ja) * | 1999-01-06 | 2002-10-29 | ジェネンテック・インコーポレーテッド | インシュリン様成長因子(igf)i変異体 |
JP3971108B2 (ja) | 1999-01-06 | 2007-09-05 | ジェネンテック・インコーポレーテッド | インシュリン様成長因子(igf)i突然変異体 |
US20030100505A1 (en) | 1999-11-01 | 2003-05-29 | Chiron Corporation | Compositions and methods of therapy for IGF-I-responsive conditions |
MXPA03007042A (es) * | 2001-02-09 | 2004-05-24 | Genentech Inc | Cristalizacion de igf-1. |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
KR20060003862A (ko) | 2003-03-14 | 2006-01-11 | 네오스 테크놀로지스, 인크. | 수용성분기폴리머 및 그 접합체 |
AU2004238364A1 (en) | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Spacer moiety for poly(ethylene glycol) -modified peptides |
US7833964B2 (en) | 2003-08-21 | 2010-11-16 | Tercica, Inc. | Methods of reducing visceral fat by increasing levels of insulin-like growth factor-I (IGF-I) |
ATE536186T1 (de) | 2003-09-12 | 2011-12-15 | Tercica Inc | Verfahren zur behandlung von igf-1 (insulin-like growth factor 1)-mangel |
EP1674113A1 (en) | 2004-12-22 | 2006-06-28 | F. Hoffmann-La Roche Ag | Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol) |
ES2532089T3 (es) | 2005-06-02 | 2015-03-24 | Ipsen Biopharmaceuticals, Inc. | GH e IGF-1 para el tratamiento de trastornos del crecimiento |
US20090169491A1 (en) | 2006-03-06 | 2009-07-02 | Caregen Co., Ltd | Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses |
UA97953C2 (ru) * | 2006-06-09 | 2012-04-10 | Новартіс Аг | Стабилизированные полипептиды инсулиноподобного фактора роста |
RU2511577C2 (ru) * | 2009-07-22 | 2014-04-10 | Ипсен Фарма С.А.С. | Аналоги инсулиноподобного фактора роста-1 (igf-1), содержащие аминокислотную замену в положении 59 |
-
2010
- 2010-07-22 RU RU2012106302/10A patent/RU2511577C2/ru not_active IP Right Cessation
- 2010-07-22 BR BR112012001363A patent/BR112012001363A2/pt not_active IP Right Cessation
- 2010-07-22 MX MX2012000757A patent/MX2012000757A/es active IP Right Grant
- 2010-07-22 ES ES10773526.8T patent/ES2562260T3/es active Active
- 2010-07-22 AU AU2010275010A patent/AU2010275010B2/en not_active Ceased
- 2010-07-22 US US13/386,220 patent/US8759299B2/en not_active Expired - Fee Related
- 2010-07-22 EP EP10773526.8A patent/EP2456788B1/en not_active Not-in-force
- 2010-07-22 KR KR1020127004456A patent/KR101417872B1/ko not_active IP Right Cessation
- 2010-07-22 JP JP2012521623A patent/JP5571186B2/ja not_active Expired - Fee Related
- 2010-07-22 UA UAA201202007A patent/UA103104C2/ru unknown
- 2010-07-22 CN CN201080041981.4A patent/CN102510757B/zh not_active Expired - Fee Related
- 2010-07-22 CA CA2768621A patent/CA2768621C/en not_active Expired - Fee Related
- 2010-07-22 WO PCT/US2010/002062 patent/WO2011011072A2/en active Application Filing
-
2012
- 2012-11-13 HK HK12111503.3A patent/HK1170748A1/zh not_active IP Right Cessation
-
2014
- 2014-05-02 JP JP2014095141A patent/JP2014169309A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2768621A1 (en) | 2011-01-27 |
US20120190616A1 (en) | 2012-07-26 |
AU2010275010A1 (en) | 2012-02-09 |
RU2012106302A (ru) | 2013-08-27 |
HK1170748A1 (zh) | 2013-03-08 |
WO2011011072A2 (en) | 2011-01-27 |
CA2768621C (en) | 2016-04-05 |
AU2010275010B2 (en) | 2013-10-24 |
CN102510757A (zh) | 2012-06-20 |
MX2012000757A (es) | 2012-08-03 |
KR20120093828A (ko) | 2012-08-23 |
EP2456788A4 (en) | 2012-12-05 |
JP2014169309A (ja) | 2014-09-18 |
JP2012533622A (ja) | 2012-12-27 |
WO2011011072A3 (en) | 2011-04-07 |
EP2456788B1 (en) | 2015-12-16 |
CN102510757B (zh) | 2015-03-18 |
KR101417872B1 (ko) | 2014-07-09 |
BR112012001363A2 (pt) | 2016-11-08 |
RU2511577C2 (ru) | 2014-04-10 |
US8759299B2 (en) | 2014-06-24 |
EP2456788A2 (en) | 2012-05-30 |
JP5571186B2 (ja) | 2014-08-13 |
ES2562260T3 (es) | 2016-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA103104C2 (ru) | Аналоги инсулиноподобного фактора роста-1 (igf-1), содержащие аминокислотную замену в положении 59 | |
MX2010002460A (es) | Complejos de arn y peptidos cationicos para transfeccion y para inmunoestimulacion. | |
RU2017119773A (ru) | Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение | |
JP2014508510A5 (ru) | ||
MX2011008094A (es) | Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos. | |
CN105324397A (zh) | 胰岛素-肠促胰岛素缀合物 | |
MX2011011960A (es) | Peptidos penetradores de celulas. | |
MX2009012675A (es) | Tensioactivos reconstituidos que tienen propiedades mejoradas. | |
MX2011013183A (es) | Polipeptidos de la hormona de crecimiento y metodos de preparacion y su uso. | |
EA201590525A1 (ru) | Слитые белки для лечения метаболического синдрома | |
MX359516B (es) | Composiciones y metodos para prevenir o tratar enfermedades, afecciones, o procesos caracterizados por la proliferacion abrellante de fibro blasto y deposicion de matriz extracelular. | |
MX2009004362A (es) | Compuestos mediante benzoilo amino heterociclilo util en el tratamiento de una enfermedad a traves de glk. | |
WO2009007714A3 (en) | Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour | |
RU2011147083A (ru) | Новый вариант эксендина и его конъюгат | |
JP2012518420A5 (ru) | ||
EP2573109A3 (en) | Peptide vaccines comprising Seq Id 101, 80 or 100 for cancers expressing tumor-associated antigens | |
EA201101525A1 (ru) | Фармацевтическая композиция | |
TN2011000558A1 (en) | Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c) | |
MX2009004467A (es) | Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk). | |
IN2012DN02861A (ru) | ||
MX2010010495A (es) | Uso de variantes del factor de crecimiento similar a la insulina (igf-i) pegiladas para el tratamiento de trastornos neuromusculares. | |
SG10201406288SA (en) | Multimeric forms of antimicrobial peptides | |
NZ708091A (en) | Stabilized insulin-like growth factor polypeptides | |
NZ590469A (en) | Treatment of rheumatoid arthritis with human beta defensins (1-4) | |
WO2010128521A3 (en) | Short-chain peptides as parathyroid hormone (pth) receptor agonist |